Pharmaceutical formulations and marketing operations in North India.
Annual revenue $180,953 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Alcea Biotech

Alcea Biotech is a company. Alcea Biotech offers products and services including ROZALCEA-10/20 and INSURIZE XR-30/60.

  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Legal Name Alcea Biotech Pvt. Ltd
  • Jurisdiction Delhi, Delhi, India
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $180.95 K (USD)
    30.71
    as on Mar 31, 2023
  • Net Profit
    $7.29 K (USD)
    18.85
    as on Mar 31, 2023
  • EBITDA
    $17.18 K (USD)
    70.13
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Alcea Biotech

Alcea Biotech offers a comprehensive portfolio of products and services, including ROZALCEA-10/20 and INSURIZE XR-30/60.

Product name locked
Category locked
Primary

Antibiotic formulations are provided for various treatments

Product name locked
Category locked
Locked

Extended-release formulations are supplied for cardiac management

Funding Insights of Alcea Biotech

Premium access

Detailed funding history for Alcea Biotech

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Alcea Biotech

Investments
Premium access

Investment portfolio details for Alcea Biotech

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Alcea Biotech

Premium access

Detailed financials for Alcea Biotech

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Alcea Biotech Comparisons

Alcea Biotech Primary company
Description
Pharmaceutical formulations and marketing operations in Nort...
Location
-
Founded Year
-
Annual Revenue
$180.95 K (USD)
Net Profit
$7.29 K (USD)
EBITDA
$17.18 K (USD)
Employees
Not available
Premium access

Peer comparison for Alcea Biotech

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Alcea Biotech

Premium access

Detailed competitors of Alcea Biotech

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Alcea Biotech

Premium access

Complete news archive for Alcea Biotech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alcea Biotech

Annual revenue of Alcea Biotech is $180.95K as on Mar 31, 2023.

Alcea Biotech is recognized as a young pharmaceutical company headquartered in Delhi, where marketing operations have been established in North India with a notable presence in major institutes. A robust portfolio has been created by the company, encompassing formulations for antibiotics, gastrointestinal treatments, cardiac care, general and neuro applications, psychiatric needs, and pain management. Products such as ROZALCEA and INSURIZE are offered, reflecting a commitment to healthcare solutions that are distributed through established channels.

Alcea Biotech offers ROZALCEA-10/20 and INSURIZE XR-30/60.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available